BioCentury
ARTICLE | Clinical News

Diastat: Completed a Phase III trial in 90 evaluable patients. A second trial should be completed in time to allow an NDA filing in 1995. A larger, safety expos

April 24, 1995 7:00 AM UTC

Athena Neurosciences Inc. (ATHN), South San Francisco Product: Diastat, viscous solution of diazepam, for rectal use Indication: Home treatment of acute repetitive seizures of epilepsy Status: Comple...